Learn More
AIMS Fascin-1, ezrin and paxillin, cytoskeleton-associated proteins, have been implicated in several human cancers, but their role in laryngeal squamous cell carcinoma (LSCC) is unknown. We investigated the association of their expression and clinicopathologic factors and their prognostic value in LSCC. MATERIALS AND METHODS Quantitative RT-PCR and(More)
Our study focuses on a set of laryngeal tumors that show reduced RUNX3 expression in the absence of transcriptional silencing of tumor suppressor gene RUNX3 by aberrant methylation of CpG islands. We report that the loss of expression of RUNX3 correlates with up-regulation of miR-106b in human laryngeal carcinoma tissue. The downregulation of RUNX3 is(More)
BACKGROUND Laser surgery and radiotherapy are commonly used to treat glottic cancer. OBJECTIVE OF REVIEW To compare outcomes and cost of laser surgery versus radiotherapy for T1-T2N0 glottic cancer. TYPE OF REVIEW Meta-analysis. SEARCH STRATEGY The Cochrane Central Register of Controlled Trials, Ovid MEDLINE® In-Process & Other Non-Indexed Citations,(More)
Overexpression of the metastasis-associated gene 1 (MTA1) has previously been found to be associated with progression of various cancer types to the metastasis stage. The function of MTA1 in laryngeal squamous cell carci-noma (LSCC) remains unclear. To explore the significance of MTA1 in the invasion and migration processes in LSCC, gene transfection and(More)
OBJECTIVE To screen out recurrent-associated gene in expression pattern of laryngeal squamous cell carcinoma(LSCC). METHOD By cDNA array chip containing 18,000 gene, the gene expression pattern of cancer and normal mucosal tissues in 2 cases of LSCC, were compared and analyzed. RESULT 1. 218 genes expressed repeatedly and differentially in LSCC were(More)
OBJECTIVE To probe the mutations of RB gene in laryngeal carcinoma, and the relation between it and the clinical phase. METHOD The mutations were detected by PCR-SSCP (polymerase chain reaction-single strand conformation polymorphism). RESULT In laryngeal carcinoma, the mutations were identified in 14(15.5%) of 90 samples, of which 2 were large(More)
Laryngeal cancer is one of the largest subgroups of head and neck cancers. In addition to smoking and alcohol consumption, genetic polymorphisms are also risk factors for the development of laryngeal cancer. However, the exact relation between genetic variants and pathogenesis of laryngeal cancer has remained elusive. The aim of this study was to examine(More)
OBJECTIVE To study the relationship between lymphatic vessel density and clinicopathological features of laryngeal squamous cell carcinoma. METHOD The lymph vessels, 40 specimens of LSCC and normal mucosa, were quantitated by SABC immunohistochemistry staining with lymphatic endothelial marker oncofetal antigen M2A Monoclonal antibody (D2-40). RESULT(More)
DNA topoisomerase II-α (Topo II-α) is essential for numerous cell processes, including DNA replication, transcription, recombination, and chromosome separation and condensation. Altered Topo II-α expression may lead to carcinogenesis and cancer progression. The aim of the present study was to investigate the association between Topo II-α expression levels(More)
The pathogenesis of laryngeal cancer (LC) is unclear. Published data indicate that micro RNAs (miRNA) play an important role in the pathogenesis of cancer. This study aims to elucidate the role of miR-193b in the tumor tolerance of LC. High levels of miR-193b were detected in LC cells as well as in the culture supernatant. Interleukin (IL)-10-expressing Mos(More)